Informationen:
Fehler:
ID
40047
Beschreibung
Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.; ODM derived from: https://clinicaltrials.gov/show/NCT01541189
Link
https://clinicaltrials.gov/show/NCT01541189
Stichworte
Versionen (1)
- 10.03.20 10.03.20 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
10. März 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hypertension NCT01541189
Eligibility Hypertension NCT01541189
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Hypertension NCT01541189
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Essential Hypertension | Therapy naive | Antihypertensive therapy
Item
naive primary hypertension patients or primary hypertensive patients on mono antihypertensive therapy:
boolean
C0085580 (UMLS CUI [1])
C0919936 (UMLS CUI [2])
C0585941 (UMLS CUI [3])
C0919936 (UMLS CUI [2])
C0585941 (UMLS CUI [3])
Therapy naive | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean
Item
all treatment-naive patients need to have 140mmhg≤mssbp<180mmhg and 90mmhg≤msdbp< 110mmhg at visit 1
boolean
C0919936 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive therapy | Sitting systolic blood pressure mean | Sitting diastolic blood pressure mean | Time Period Screening | Time Period Therapeutic
Item
for patients on mono antihypertensive therapy, mssbp/msdbp should <160/100mmhg at visit 1 (the beginning of screening period); and at visit 2(the beginning of theraputic period), they should have mssbp≥140 mmhg and <180mmhg and msdbp≥90 mmhg and <110mmhg
boolean
C0585941 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C1948053 (UMLS CUI [4,1])
C1710032 (UMLS CUI [4,2])
C1948053 (UMLS CUI [5,1])
C0302350 (UMLS CUI [5,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319894 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C1948053 (UMLS CUI [4,1])
C1710032 (UMLS CUI [4,2])
C1948053 (UMLS CUI [5,1])
C0302350 (UMLS CUI [5,2])
Hypertension, severe
Item
severe hypertension
boolean
C4013784 (UMLS CUI [1])
Malignant Hypertension
Item
malignant hypertension
boolean
C0020540 (UMLS CUI [1])
Secondary hypertension
Item
secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Renal dysfunction | Creatinine measurement, serum
Item
renal dysfunction(serum creatinine > 2.0mg(176.8μmol/l)at visit 1)
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
Liver disease
Item
hepatic disease
boolean
C0023895 (UMLS CUI [1])
Hypertensive Encephalopathy | Cerebrovascular accident
Item
history of hypertensive encephalopathy or cerebrovascular accident within 6 months
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
Myocardial Infarction | Coronary revascularisation
Item
history of myocardial infarction, coronary revascularization within 6 months
boolean
C0027051 (UMLS CUI [1])
C0877341 (UMLS CUI [2])
C0877341 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
patietns with hba1c >8% at visit 1
boolean
C0474680 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women in pregnancy and lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Absent
Item
potentially fertile female patients not using effective contraceptive methods
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Hypersensitivity Investigational New Drugs
Item
be allergy to study drug.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Eligibility Criteria Study Protocol
Item
other protocol defined inclusion/exlusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])